Prurigo Nodularis

Dermatology·MeSH: Prurigo

5 drugs in development·4 companies·12 clinical trials

Drug Pipeline by Phase

Phase 3(1)

Drug	Company
incb054707	Incyte Corp. (INCY)

Phase 2(2)

Drug	Company
rocatinlimab	AMGEN INC (AMGN)
zumilokibart	Apogee Therapeutics, Inc. (APGE)

Phase 2/Phase 3(2)

Drug	Company
haduvio	Trevi Therapeutics, Inc. (TRVI)
nalbuphine er	Trevi Therapeutics, Inc. (TRVI)

BioSniper tracks 5 drugs in development for Prurigo Nodularis across 4 companies.

There are 12 clinical trials targeting Prurigo Nodularis tracked by BioSniper.

Full trial data, competitive analysis, and AI-powered pipeline tracking.